List of vaccines available in the market
This list includes trade name, manufacturer, common abbreviation, type and route of administration, and primary and booster doses for pediatric population. It also includes link to the vaccines' product information.
This is helpful especially for starting pediatricians
1. Vaccine Trade Name Abbreviation Manufacturer Type/Route Primary Booster
BCG BCG (china, japan) ID at birth
Diphtheria, Tetanus,
acellular Pertussis
Infanrix DTaP
3 in 1
GSK
Inactivated Toxoids and
Bacterial / IM
2, 4, 6 months old
15 to 20 months of age and another booster
dose at 4 to 6 years of age
Daptacel Sanofi - Canada 2, 4, 6 months old
15 to 20 months of age and another booster
dose at 4 to 6 years of age
Diphtheria, Tetanus,
acellular Pertussis,
Inactivated Polio
Tetraxim DTP-IPV
4 in 1
Sanofi - France
3 doses, 1 to 2 month interval starting 2
months old
2, 4, 6 months old OR
2, 3, 4 months old
1 year after primary shots AND
5 to 11 yrs old OR
11 to 15 yrs old
Quadracel Sanofi - Canada 2, 4, 6, 18 months old
booster dose with Adacel (DTP) is needed if
fourth dose was given after 4th birthday
Diphtheria, Tetanus,
whole cell Pertussis,
Hepa B, Hib
Quinvaxem
DTwP-HepaB/Hib
5 in 1
Novartis 3 doses as early as 6 weeks old 13-24 months old
Easy 5-TT Panacea 6, 10, 14 weeks old no data available
Diphtheria, Tetanus,
acellular Pertussis,
Inactivated Polio,
Hib
Infanrix IPV Hib
DTap-IPV/Hib
5 in 1
GSK - Canada 3 doses: 2, 4, 6 months old
2 yrs old OR
6 months from last primary dose
Pentaxim Sanofi - France
2 doses: 2, 4 months old
3 doses: 2, 4, 6 months old
if primary is 2 doses then booster is at 11
months
if primary is 3 doses then booster is at 2 yrs
old
Pediacel Sanofi 2, 4, 6, 18 months old booster with Adacel (DTP)
Diphtheria and
Tetanus Toxoid,
acellular Pertussis,
inactivated Polio,
Hepa B
(recombinant) and
Hib
Infanrix Hexa
DTaP-IPV/Hib/
Hepa B
6 in 1
GSK 6 weeks old to 2 yrs old 12 to 23 months old
Hexaxim Sanofi - France
2 primary doses at least 8 weeks apart OR
3 primary doses at least 4 weeks apart
starting at 6 weeks of age
6, 10 ,14 weeks OR 2, 4, 6 months
2, 3, 4 months of 3, 4, 5 months old
2 yrs old OR at least 6 months after primary
doses
Hepatitis A
Havrix Jr
Hepa A
GSK
Inactivated Viral / IM
12 months old and above 6-12months after
Avaxim Pedia Sanofi 2 yrs old and above 6-36 months after
Livac A
Zhejiang Phukang
Biotech
Live attenuated / SC 1 1/2 yrs old and above no booster
Hepatitis B
Engerix Pedia
Hepa B
GSK
Recombinant viral / IM
neonates until 19 yrs old: 10mcg, 0-1-6 mo
interval
11-15yo: 20 mcg, 0-6 mo interval
none
Euvax Pedia LG Life Sciences
neonates to 15 yo: 10mcg, 0-1-6 mo
interval
none
Genevac B Pedia Serum Institute
10 mcg in 0.5ml
• 6,10,14 weeks for infants
• 0,1,6 months
• 0,1,2 month (rapid schedule)
not recommended unless AntiHBS is <10
IU/L
Adult dose 20 mcg in 1ml at 20 yrs and
above
Revac B Bharat Biotech birth to <10yo: 0,1,6 months none
Recombivax HB Merck
birth to <19yo: 0,1,6 months of 0.5ml
11 to 15 yo: 0,1, 6 months of 0.5ml or 0, 4-
6 of 1ml
20 and older: 0, 1, 6 months of 1ml
if the anti-HBs level is less than 10 mIU/mL
at 1 to 2 months after the third dose
2. Hepatitis A and B Twinrix Hepa A and B GSK
Inactivated/Recombinant
Viral / IM
0,1,6 months
0, 7, and 21 to 30 days (rapid)
12 months after rapid schedule
Hepatitis B IG Hepabig Hepa B IG Vizcarra Immuneglobulin / IM
within 48 hrs from birth up to 5 days (100-
200 IU)
2-3 months after (32-48 IU/kg)
Human
Papillomavirus
Cervarix
HPV
(type 16, 18)
GSK
Recombinant viral / IM
9 to 25 yo: 0,1, 6 months interval none
Gardasil
HPV (types 6, 11,
16, 18)
Merck 9 to 26 yo: 0, 2, 6 months interval none
Gardasil 9 HPV Merck
9 to 14 yo: 2 dose - 0, 6-12mo; 3 dose - 0,
2, 6 mo
15 to 26 yo: 3 dose - 0, 2, 6 mo
2 dose sched: 6-12 mo after
Influenza (quadrivalent)
Fluarix Tetra
Flu
GSK
Split virion, inactivated / IM
6 mo to 9 yo, 1st dose: 2 dose sched at least 4 wks after
Fluquadri Junior Sanofi
Fluquadri Jr 6 to 35 months (0.25ml)
Fluquadri 36 months and above (0.5ml)
1 month after then annual thereafter
Influvac Tetra Abbott Inactivated Viral / IM or SC 3 yrs and above annual
Japanese EncephalitisImojev JE Sanofi
Monovalent live attenuated /
SC
9 months and above 1-2 years after
Measles, Mumps, Rubella
MMR II
MMR
Merck Live Attenuated Viral / SC
12 to 15 months old
if with outbreak, 9 months, 12-15 months
old
4 to 6 years old
Priorix GSK Live Attenuated Viral / SC or
IM
12 months of age 1 month after or 18 months old or 4-6 yrs old
Trimovax Sanofi 12 months, 9 months if with outbreak 3 to 6 years old
Measles, Mumps,
Rubella, Varicella
Priorix - Tetra
MMRV
GSK
Live Attenuated Viral / SC
9 months to 12 years old
6 weeks to 3 months after
or 15 months to 6 yrs old (as second dose
from MMR/V)
Proquad Merck
12 months to 12 years old: 1st dose, 12-15
mo old
4-6 yrs old
at least 1 month prior to Measles or MMRII
and 3 months prior to Varicella vaccine
Meninggococcal
Menactra
MenA,C,W-135,Y
Sanofi Inactivated Bacterial / IM
9 to 23 months of age: Two doses, three
months apart.
2 yrs old to 55 years of age: A single dose.
15 to 55 years old (if at risk)
Nimenrix GSK
Polysaccharide conjugate /
IM
12 months old and above every 5 years (if at risk)
Mencevax GSK Polysaccharide vaccine / SC 2 yrs old and above if at risk depends on local guideliens
Measles M-Vac Measles
freeze dried Live vaccine /
SC
9 months none
Pneumocococcal
Pneumovax 23 PPSV23 Merck
Inactivated Bacterial / SC or
IM
2 years of age and older (if at risk)
50 years of age and older
none
Prevnar 13 PCV13 Pfizer Inactivated Bacterial / IM
6 wks old to 5 years: 2, 4, 6, and 12–15
months of age
Children 6 through 17 years of age: a
single dose
Adults 18 years and older: a single dose
Catch up if unvaccinated:
7-11 mos of age:
1st 2 doses at least 4 wks apart; 3rd dose
after 1 yr old separated from the 2nd dose by
at least 2 months
12-23 mos of age: 2 doses at least 2 months
apart
24 mos to 5 yrs of age (prior to the 6th
birthday)
3. Pneumocococcal
Synflorix PCV10 GSK Polysaccharide vaccine / IM
6 wks to 2 yrs old
6 wks to 6 months: 3doses, 1 month
interval
if unvaccinated: 7 mos to 11 mos: 2 doses,
1 month interval
if unvaccinated: 12-23 mos: 2 doses, 2
month interval
4th dose: at least 6 months after primary
sched
3rd dose: 2 yrs old (at least 2 months after
primary sched)
no booster
Rabies
Rabipur
Rabies
Zhiron
Inactivated Vaccine / IM
Pre exposure: 0, 7, 21 or 28 days
Post exposure: 0, 3, 7, 14, 28 days
every 2 to 5 yearsSpeeda Liaoning
Verorab Sanofi
Rotavirus
Rotarix RV1 GSK
Live Viral / Oral (liquid)
2 doses: 1st between 6 and 14 weeks of
age
2nd dose not less than 4 wks from 1st dose,
until 24 wks of age
Rotateq RV5 Merck 3 doses: 1st is 6 to 12 wks of age
2nd 4 to 10 wks later, 3rd is 4 to 10 wks from
2nd dose. 3rd dose should be before 32 wks
of age
Shingles Zostavax Varicella-Zoster Merck Live attenuated vaccine / SC 50 yrs old and older none
Tetanus, (reduced)
Diphtheria,
(reduced) Pertussis
Boostrix
Tdap
GSK Inactivated Bacterial
(acellular combined with
toxoid) / IM
4 yrs old and older
may be given to adults requiring diphtheria
tetanus vaccine
Adacel Sanofi 10 yrs to 64 yrs old none. single dose only
Typhoid
Typbar
Typhoid
Bharat Biotech
Purified Vi capsular
Polysaccharide / IM
2 yrs and above (or 2 wks before
exposure)
single dose, unless at risk. if at risk, every
3yrs
Typhim Sanofi
Purified polysaccharide
capsule / IM
2 yrs and above single dose
Varicella
Mevac Vari
Varicella
Changchun BCHT
Live attenuated virus (Oka
strain) / SC
12 months and above data not available
Varivax Merck
Live virus varicella vaccine /
SC
12 months and above
12mo-12yrs minimum interval of 3 months
between doses
13 yrs and above 4 weeks interval between
doses
Varilix GSK
Live attenuated virus (Oka
strain) / SC
9 months and above (Or 72 hrs within
exposure)
at least 6 weeks after